<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-116806</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Analysis of several containment measures of pharmaceutical expenditure in an Ambulatory Surgery Centre</dc:title>
<dc:description xml:lang="en">Objective. In the context of the current crisis, sustainability of National Health Service must be considered a priority issue. To compare several cost saving measures in drug expenditure due to outpatient drug treatment after surgery in an Ambulatory Surgical Centre. Material and method. Pharmaco-economic analysis of cost minimization of ambulatory pharmaceutical services during the year 2011. A total of 3,346 patients were operated on and discharged on the same day, were included. Treatments were collected from the discharge report of each patient. We compared changes in real outpatient drug spending after separately applying each of the following measures: 1) increasing the co-payment; 2) improving the quality of prescribing; 3) dispensing by units of drugs through pharmacies, and 4) dispensing through the hospital pharmacy service. Results. The real outpatient pharmaceutical expenditure was 29,454.21 &#128;. Increasing the co-payment mean a transfer of 2,091.82 &#128; from the funding institutions to users. Improving the quality of prescriptions, dispensing through units of drugs in the pharmacy, and dispensing through the hospital pharmacy service led to a pharmaceutical expenditure of 24,215.14 &#128;, 21,766.24 &#128; and 7,827.71 &#128;, respectively. Conclusions. Only considering co-payment to contain pharmaceutical expenditure arising from prescribing in an Ambulatory Surgical Centre is the least effective measure. The most effective measure, for this purpose, is the supply of drugs through the hospital pharmacy service (AU)</dc:description>
<dc:creator>Esteban, J. L</dc:creator>
<dc:creator>Porras, I</dc:creator>
<dc:creator>León, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. En el actual contexto de crisis, la sostenibilidad del Sistema Nacional de Salud debe considerarse prioritaria. Este estudio se propone comparar varias medidas de ahorro en el gasto farmacéutico debido al tratamiento farmacológico ambulatorio posquirúrgico de una Unidad de Cirugía Mayor Ambulatoria de tipo autónomo. Material y método. Análisis farmacoeconómico retrospectivo de minimización de costes del gasto debido a la prestación farmacéutica ambulatoria de una Unidad de Cirugía Mayor Ambulatoria durante 2011. Se incluyeron 3.346 pacientes intervenidos quirúrgicamente y dados de alta el mismo día. Los tratamientos se recogieron del informe de alta de cada paciente. Se compararon los cambios en el gasto farmacéutico ambulatorio real después de aplicar, por separado, cada una de las siguientes medidas: 1) aumento del copago; 2) mejora de la calidad de la prescripción; 3) dispensación por unidades en las oficinas de farmacia, y 4) dispensación a través del Servicio de Farmacia Hospitalaria. Resultados. El gasto farmacéutico ambulatorio real fue de 29.454,21 &#128;. El aumento del copago supone una transferencia de 2.091,82 &#128; del gasto de financiadores a usuarios. Mejorar la calidad de las prescripciones, dispensar por unidades en las oficinas de farmacia, y dispensar a través del Servicio de Farmacia Hospitalaria situaron el gasto farmacéutico en 24.215,14 &#128;, 21.766,24 &#128; y 7.827,71 &#128;, respectivamente. Conclusiones. La sola consideración del copago para contener el gasto farmacéutico derivado de la prescripción ambulatoria de medicamentos en una Unidad de Cirugía Mayor Ambulatoria es la medida menos eficaz. La más eficaz, para este fin, es la dispensación de los medicamentos a través del Servicio de Farmacia Hospitalaria (AU)</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;60(9): 498-503, nov. 2013.</dc:source>
<dc:identifier>ibc-116806</dc:identifier>
<dc:title xml:lang="es">Análisis de varias medidas de contención del gasto farmacéutico ambulatorio en una Unidad de Cirugía Mayor Ambulatoria</dc:title>
<dc:subject>^d31495^s22066</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d30152^s22048</dc:subject>
<dc:subject>^d557^s22045</dc:subject>
<dc:subject>^d557^s22066</dc:subject>
<dc:subject>^d7610</dc:subject>
<dc:subject>^d30152^s22066</dc:subject>
<dc:subject>^d557^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d32137^s22018</dc:subject>
<dc:subject>^d32137^s22045</dc:subject>
<dc:subject>^d3378^s22045</dc:subject>
<dc:subject>^d31495^s22049</dc:subject>
<dc:subject>^d30152^s22083</dc:subject>
<dc:subject>^d3378^s22018</dc:subject>
<dc:subject>^d557^s22018</dc:subject>
<dc:subject>^d31495^s22048</dc:subject>
<dc:type>article</dc:type>
<dc:date>201311</dc:date>
</metadata>
</record>
</ibecs-document>
